The Role of Gm4951 in Nonalcoholic Fatty Liver Disease
Gm4951 在非酒精性脂肪肝中的作用
基本信息
- 批准号:10544345
- 负责人:
- 金额:$ 36.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AllelesBody WeightCharacteristicsCirrhosisCouplingDataDevelopmentDietDiseaseDisease modelEnergy MetabolismEnzymesFamilyFatty LiverFutureGenesGeneticGenetic ScreeningGenetic TranscriptionGenetic VariationGerm-Line MutationGoalsGuanosine Triphosphate PhosphohydrolasesHealthHepaticHepatocyteHigh Fat DietHomologous GeneHumanHydroxysteroidsIn VitroInsulinInsulin ResistanceInterferon Type IIInterferonsKnock-in MouseKnock-outKnowledgeLipidsLiverLocationLoxP-flanked alleleMapsMass Spectrum AnalysisMeiosisMetabolicMissense MutationMolecularMusMutant Strains MiceMutationNamesObesityOxidoreductasePathogenesisPathway interactionsPatternPhenotypePhysiologicalPrevalencePrimary carcinoma of the liver cellsProcessPromoter RegionsProteinsProteomicsPublic HealthRegulationResearchRoleSeriesSeveritiesSliceTestingTimeTissuesTranscriptional RegulationTranslatingWeight GainWorkadenoviral mediatedchronic liver diseasecombatdietarydisease phenotypeexperimental studyfatty acid oxidationglucose metabolisminducible gene expressioninsightlipid biosynthesislipid metabolismmembermouse modelmutantnew therapeutic targetnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnovel strategiesnovel therapeutic interventionoverexpressionoxidationpreventscreeningtranscription factor
项目摘要
PROJECT SUMMARY
Nonalcoholic fatty liver disease (NAFLD) is becoming a global human health problem. Our long-term goal is
to understand molecular mechanisms of NAFLD, and to translate this knowledge into novel therapeutic strategies.
Due to the physiologic similarities between humans and mice, and the propensity of mice to develop a disease
closely mimicking NAFLD when fed a high fat diet (HFD), mice have provided us with fundamental insights into
NAFLD pathogenesis. In humans and mice, genetic variation influences the rate and severity of hepatosteatosis
under a given set of environmental conditions. To identify genes that influence the process, we utilized unbiased
forward genetic screening and highly automated meiotic mapping to identify mutations that cause NAFLD in mice
sensitized by a HFD. Two semi-dominant missense alleles of predicted gene 4951 (Gm4951), named Oily and
Carboniferous, were detected in this screen. As distinct from most NAFLD mutants that are associated with
obesity, our preliminary data showed that Gm4951 deficient mice had dramatically increased hepatic lipid
accumulation without a concomitant increase of body weight on a HFD. Gm4951 was highly expressed in
hepatocytes. Knockout of Gm4951 increased lipid content and overexpression of Gm4951 decreased lipid
content of primary hepatocytes in vitro, suggesting hepatocyte-intrinsic regulation of lipid content. Gm4951
knockout livers showed decreased expression of lipid oxidation genes. Mass spectrometry analysis of
endogenous GM4951 interacting proteins revealed interaction with lipid droplet protein Hydroxysteroid 17β-
dehydrogenase 13 (HSD17B13) and lipid oxidation enzymes. Moreover, the transcription of Gm4951 in
hepatocytes was activated by interferon gamma (IFN-γ), which effectively decreased lipid content, much as when
GM4951 was overexpressed. These results led to our central hypothesis that GM4951 is critical for promoting
lipid oxidation, and limits hepatic lipid accumulation. To test this hypothesis, we propose to pursue three Specific
Aims. Aim 1 will further investigate the development of NAFLD in GM4951 deficient mice. Aim 2 will determine
the precise mechanistic role of GM4951 in regulating lipid metabolism. Aim 3 will study the transcriptional
regulation of Gm4951, including the liver-specific expression pattern and the inducible expression by IFN-γ.
Understanding how to activate GM4951 and what’s the human homolog of GM4951 would offer approaches to
preventing or treating NAFLD. These will be studied in Aim 3 as well. The NAFLD phenotype caused by GM4951
deficiency is fundamentally distinct from the classic obesity-associated NAFLD mouse models. GM4951 is
specifically expressed in the liver and operates there to limit lipid accumulation. Thus, finding ways to activate
GM4951 will provide a new means of reducing hepatic lipid content. Completion of the proposed work will
suggest new therapeutic targets to combat NAFLD.
项目总结
非酒精性脂肪性肝病(NAFLD)正成为全球人类健康问题。我们的长期目标是
了解NAFLD的分子机制,并将这些知识转化为新的治疗策略。
由于人类和老鼠在生理上的相似之处,以及老鼠患疾病的倾向
小鼠与喂食高脂饮食(HFD)时的NAFLD非常相似,它为我们提供了对
NAFLD的发病机制。在人类和小鼠中,基因变异影响肝骨病的发生率和严重程度
在给定的环境条件下。为了确定影响这一过程的基因,我们使用了无偏倚
正向基因筛查和高度自动化的减数分裂图谱以识别导致小鼠NAFLD的突变
用HFD致敏。预测基因4951(Gm4951)的两个半显性错义等位基因,命名为Oy和
石炭纪,在这个屏幕上被检测到。与大多数NAFLD突变体不同的是,
肥胖,我们的初步数据显示,Gm4951缺陷小鼠的肝脏脂质显著增加
在HFD上积累而不伴随体重增加。Gm4951在细胞中高度表达
肝细胞。Gm4951基因敲除可增加脂质含量,过表达Gm4951可降低血脂
体外培养的原代肝细胞的含量,提示肝细胞对脂质含量的内在调节。Gm4951
基因敲除的肝脏显示脂质氧化基因的表达减少。质谱学分析
内源性GM4951相互作用蛋白与脂滴蛋白羟基类固醇17β-
脱氢酶13(HSD17B13)和脂质氧化酶。此外,Gm4951基因的转录在
肝细胞被干扰素-γ激活,这有效地降低了脂肪含量,与
GM4951基因过表达。这些结果导致了我们的中心假设,即GM4951对于促进
脂肪氧化,并限制肝脏脂肪堆积。为了验证这一假设,我们提出了三个具体的
目标。目的1进一步研究GM4951基因缺陷小鼠非酒精性脂肪肝的发生。目标2将决定
GM4951在调节脂代谢中的确切机制作用。目标3将研究转录
Gm4951的调控,包括肝脏特异性表达模式和干扰素-γ的诱导表达。
了解如何激活GM4951以及GM4951的人类同源基因将提供以下方法
预防或治疗非酒精性脂肪肝。这些也将在目标3中进行研究。GM4951引起的非酒精性脂肪肝表型
缺乏症从根本上不同于经典的肥胖相关的NAFLD小鼠模型。GM4951是
在肝脏中特异表达,并在那里发挥作用,限制脂肪堆积。因此,找到激活的方法
GM4951为降低肝脂含量提供了一种新的途径。拟议工作完成后,
建议新的治疗靶点来对抗非酒精性脂肪肝。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhao Zhang其他文献
Zhao Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhao Zhang', 18)}}的其他基金
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease
Gm4951 在非酒精性脂肪肝中的作用
- 批准号:
10339213 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Regulation, function, and impact of developmental retrotransposon activation
发育逆转录转座子激活的调节、功能和影响
- 批准号:
10177576 - 财政年份:2021
- 资助金额:
$ 36.08万 - 项目类别:
Regulation, function, and impact of developmental retrotransposon activation
发育逆转录转座子激活的调节、功能和影响
- 批准号:
10549855 - 财政年份:2021
- 资助金额:
$ 36.08万 - 项目类别:
Quantitative characterization of neuronal trans-SNARE complexes using DNA origami
使用 DNA 折纸对神经元 trans-SNARE 复合物进行定量表征
- 批准号:
10281683 - 财政年份:2021
- 资助金额:
$ 36.08万 - 项目类别:
Regulation, function, and impact of developmental retrotransposon activation
发育逆转录转座子激活的调节、功能和影响
- 批准号:
10373055 - 财政年份:2021
- 资助金额:
$ 36.08万 - 项目类别:
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes
KBTBD2 在脂肪营养不良、胰岛素抵抗和糖尿病中的作用
- 批准号:
10468738 - 财政年份:2020
- 资助金额:
$ 36.08万 - 项目类别:
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes
KBTBD2 在脂肪营养不良、胰岛素抵抗和糖尿病中的作用
- 批准号:
10213315 - 财政年份:2020
- 资助金额:
$ 36.08万 - 项目类别:
Somatic transposition-mediated genome variegation during development, disease and aging conditions
发育、疾病和衰老条件下体细胞转座介导的基因组变异
- 批准号:
9001476 - 财政年份:2015
- 资助金额:
$ 36.08万 - 项目类别:
Somatic transposition-mediated genome variegation during development, disease and aging conditions
发育、疾病和衰老条件下体细胞转座介导的基因组变异
- 批准号:
10043992 - 财政年份:2015
- 资助金额:
$ 36.08万 - 项目类别:
Somatic transposition-mediated genome variegation during development, disease and aging conditions
发育、疾病和衰老条件下体细胞转座介导的基因组变异
- 批准号:
9349391 - 财政年份:2015
- 资助金额:
$ 36.08万 - 项目类别:
相似海外基金
Effects of probiotics on the postoperative body weight and skeletal muscle mass according to the operative methods for gastric cancer
益生菌对胃癌手术方式术后体重和骨骼肌质量的影响
- 批准号:
23K08118 - 财政年份:2023
- 资助金额:
$ 36.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Linking insufficient sleep with body weight in Black emerging adults.
将睡眠不足与黑人新生成年人的体重联系起来。
- 批准号:
10665139 - 财政年份:2023
- 资助金额:
$ 36.08万 - 项目类别:
The Role of IRX3 Neurons in the Regulation of Body Weight Homeostasis
IRX3 神经元在体重稳态调节中的作用
- 批准号:
10752469 - 财政年份:2023
- 资助金额:
$ 36.08万 - 项目类别:
Role of Central Neurotensin Signaling in the Ventral Tegmental Area for Ingestive Behavior and Body Weight
中枢神经降压素信号在腹侧被盖区对摄入行为和体重的作用
- 批准号:
10665597 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Role of Central Neurotensin Signaling in the Ventral Tegmental Area for Ingestive Behavior and Body Weight
中枢神经降压素信号在腹侧被盖区对摄入行为和体重的作用
- 批准号:
10536558 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Brainstem GABA neurons orchestrate feeding and body weight
脑干 GABA 神经元协调进食和体重
- 批准号:
BB/V016849/1 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Research Grant
Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity
限时饮食与每日持续热量限制对肥胖成人体重和结直肠癌风险标志物的影响
- 批准号:
10304332 - 财政年份:2021
- 资助金额:
$ 36.08万 - 项目类别:
The role of regulator of G protein signaling Gbeta5-R7 in neuronal control of body weight
G蛋白信号调节剂Gbeta5-R7在神经元控制体重中的作用
- 批准号:
10539336 - 财政年份:2021
- 资助金额:
$ 36.08万 - 项目类别:
Time restricted feeding versus daily calorie restriction: Effect on body weight, metabolic risk, and the gut microbiome
时间限制喂养与每日热量限制:对体重、代谢风险和肠道微生物组的影响
- 批准号:
10488263 - 财政年份:2021
- 资助金额:
$ 36.08万 - 项目类别:














{{item.name}}会员




